<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="tbc1d24-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">tbc1d24-dis</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">TBC1D24</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mucha</surname>
            <given-names>Bettina E</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Medical Genetics Service<break/>Sainte-Justine Hospital<break/>Montreal, Canada</aff>
          <email>bettina.elizabe.mucha-le.ny@umontreal.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hennekam</surname>
            <given-names>Raoul CM</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>University of Amsterdam<break/>Amsterdam, Netherlands</aff>
          <email>r.c.hennekam@amc.uva.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sisodiya</surname>
            <given-names>Sanjay</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>University College London<break/>London, United Kingdom</aff>
          <email>s.sisodiya@ucl.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Campeau</surname>
            <given-names>Philippe M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Medical Genetics Service<break/>Sainte-Justine Hospital<break/>Montreal, Canada</aff>
          <email>p.campeau@umontreal.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2015-02-26" date-type="created">
          <day>26</day>
          <month>2</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="tardbp-als" document-type="chapter"><italic toggle="yes">TARDBP</italic>-Related Amyotrophic Lateral Sclerosis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="tfr2" document-type="chapter">
<italic toggle="yes">TFR2</italic>-Related Hereditary Hemochromatosis</related-object>
      <abstract id="tbc1d24-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">TBC1D24</italic>-related disorders comprise a continuum that includes the following recognized phenotypes:</p>
          <list list-type="bullet">
            <list-item>
              <p>DOORS syndrome (<italic toggle="yes">d</italic>eafness, <italic toggle="yes">o</italic>nychodystrophy, <italic toggle="yes">o</italic>steodystrophy, mental <italic toggle="yes">r</italic>etardation, and <italic toggle="yes">s</italic>eizures): profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability/developmental delay, and seizures</p>
            </list-item>
            <list-item>
              <p>Familial infantile myoclonic epilepsy (FIME): early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability</p>
            </list-item>
            <list-item>
              <p>Progressive myoclonus epilepsy (PME): action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia</p>
            </list-item>
            <list-item>
              <p>Early-infantile epileptic encephalopathy 16 (EIEE16): epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function</p>
            </list-item>
            <list-item>
              <p>Autosomal recessive nonsyndromic hearing loss, DFNB86: profound prelingual deafness</p>
            </list-item>
            <list-item>
              <p>Autosomal dominant nonsyndromic hearing loss, DFNA65: slowly progressive deafness with onset in the third decade, initially affecting the high frequencies</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of a <italic toggle="yes">TBC1D24</italic>-related disorder is established in an individual with two <italic toggle="yes">TBC1D24</italic> pathogenic variants when the mode of inheritance is autosomal recessive (i.e., DOORS syndrome, FIME, PME, EIEE16, and DFNB86).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Hearing aids or cochlear implants as needed for hearing loss; early educational intervention, physical, occupational, and speech therapy for developmental delay; symptomatic pharmacologic management for seizures; routine management of renal and cardiac anomalies.</p>
          <p><italic toggle="yes">Surveillance:</italic> Neurology evaluations with EEGs depending on seizure frequency and/or progression of clinical manifestations; yearly audiologic evaluation to assess for possible progression of hearing loss and/or the efficacy of hearing aids; yearly dental evaluation.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Excessive ambient noise, which may exacerbate hearing loss in heterozygotes for a <italic toggle="yes">TBC1D24</italic> pathogenic variant that causes DFNA65.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Molecular genetic testing for the familial <italic toggle="yes">TBC1D24</italic> pathogenic variant(s) in older and younger sibs of a proband in order to identify as early as possible those who would benefit from early treatment of seizures and/or hearing loss.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Most <italic toggle="yes">TBC1D24</italic><bold>-</bold>related disorders are inherited in an autosomal recessive manner (DOORS syndrome, FIME, PME, EIEE16, and DFNB86). For autosomal recessive inheritance: At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">TBC1D24</italic> pathogenic variants in the family. Prenatal testing is possible for pregnancies at increased risk if the <italic toggle="yes">TBC1D24</italic> pathogenic variants have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="tbc1d24-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="tbc1d24-dis.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_tbc1d24-dis.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">TBC1D24</italic>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_tbc1d24-dis.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>DOORS syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Familial infantile myoclonic epilepsy (FIME)</p>
                    </list-item>
                    <list-item>
                      <p>Progressive myoclonus epilepsy (PME)</p>
                    </list-item>
                    <list-item>
                      <p>Early-infantile epileptic encephalopathy 16 (EIEE16)</p>
                    </list-item>
                    <list-item>
                      <p>Autosomal recessive nonsyndromic hearing loss, DFNB86</p>
                    </list-item>
                    <list-item>
                      <p>Autosomal dominant nonsyndromic hearing loss, DFNA65</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="tbc1d24-dis.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="tbc1d24-dis.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes, see <xref ref-type="sec" rid="tbc1d24-dis.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="tbc1d24-dis.Diagnosis">
        <title>Diagnosis</title>
        <p><italic toggle="yes">TBC1D24</italic>-related disorders comprise a continuum of recognized phenotypes:</p>
        <list list-type="bullet">
          <list-item>
            <p>DOORS syndrome (<italic toggle="yes">d</italic>eafness, <italic toggle="yes">o</italic>nychodystrophy, <italic toggle="yes">o</italic>steodystrophy, mental <italic toggle="yes">r</italic>etardation, and <italic toggle="yes">s</italic>eizures)</p>
          </list-item>
          <list-item>
            <p>Familial infantile myoclonic epilepsy (FIME)</p>
          </list-item>
          <list-item>
            <p>Progressive myoclonus epilepsy (PME)</p>
          </list-item>
          <list-item>
            <p>Early-infantile epileptic encephalopathy 16 (EIEE16)</p>
          </list-item>
          <list-item>
            <p>Autosomal recessive nonsyndromic hearing loss (DFNB86)</p>
          </list-item>
          <list-item>
            <p>Autosomal dominant nonsyndromic hearing loss (DFNA65)</p>
          </list-item>
        </list>
        <p>No formal diagnostic criteria have been published for any of the<italic toggle="yes">TBC1D24</italic>-related disorders.</p>
        <sec id="tbc1d24-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>The diagnosis of a <italic toggle="yes">TBC1D24</italic>-related disorder is suggested by the presence of the following features of the recognized phenotypes that comprise a phenotypic continuum. (Information on additional features appears in <xref ref-type="sec" rid="tbc1d24-dis.Clinical_Characteristics">Clinical Characteristics</xref>).</p>
          <p>
            <bold>DOORS syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">D</italic>eafness (profound sensorineural hearing loss)</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">O</italic>nychodystrophy (short/absent nails)</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">O</italic>steodystrophy (short phalanges)</p>
            </list-item>
            <list-item>
              <p>Intellectual disability/developmental delay (formerly known as mental <italic toggle="yes">r</italic>etardation)</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">S</italic>eizures</p>
            </list-item>
            <list-item>
              <p>2-oxoglutaric aciduria</p>
            </list-item>
          </list>
          <p><bold>Familial infantile myoclonic epilepsy (FIME).</bold> Early-onset myoclonic seizures</p>
          <p><bold>Progressive myoclonus epilepsy (PME).</bold> Action myoclonus, tonic-clonic seizures, progressive neurologic decline and ataxia</p>
          <p>
            <bold>Early-infantile epileptic encephalopathy 16 (EIEE16)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Early-onset seizures (unresponsive to medication), which can include myoclonic seizures or malignant migrating partial seizures of infancy</p>
            </list-item>
            <list-item>
              <p>Extrapyramidal signs (e.g., dystonia), hemiparesis, and/or autonomic signs</p>
            </list-item>
            <list-item>
              <p>Neurologic deterioration and early death</p>
            </list-item>
            <list-item>
              <p>Progressive diffuse cerebral atrophy</p>
            </list-item>
          </list>
          <p><bold>Autosomal recessive nonsyndromic hearing loss, DFNB86.</bold> Prelingual nonsyndromic sensorineural deafness (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>)</p>
          <p><bold>Autosomal dominant nonsyndromic hearing loss, DFNA65.</bold> Adult-onset nonsyndromic sensorineural deafness (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>)</p>
        </sec>
        <sec id="tbc1d24-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">TBC1D24</italic>-related disorder is established in an individual with two <italic toggle="yes">TBC1D24</italic> pathogenic variants when the mode of inheritance is autosomal recessive (i.e., DOORS syndrome, FIME, PME, EIEE16, and DFNB86) (<xref ref-type="table" rid="tbc1d24-dis.T.summary_of_molecular_genet">Table 1</xref>).</p>
          <p>
            <bold>Molecular testing approaches can include:</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">TBC1D24</italic> first. If only one or no pathogenic variant is found, deletion/duplication analysis may be considered.Note: (1) The diagnostic yield appears to be highest in individuals with all five typical features of DOORS syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>]. (2) The proportion of epilepsy caused by mutation of <italic toggle="yes">TBC1D24</italic> appears to be small, and clinically distinctive signs and symptoms have not yet been identified.</p>
            </list-item>
            <list-item>
              <p>Use of a multi-gene panel that includes <italic toggle="yes">TBC1D24</italic> and other genes of interest (see <xref ref-type="sec" rid="tbc1d24-dis.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="tbc1d24-dis.T.summary_of_molecular_genet" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">TBC1D24</italic>-Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TBC1D24</italic>
                  </td>
                  <td headers="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>DOORS syndrome: 9/18 families with all 5 major features&#x000a0;<sup>3</sup></p>
                      </list-item>
                      <list-item>
                        <p>FIME: unknown&#x000a0;<sup>4</sup></p>
                      </list-item>
                      <list-item>
                        <p>PME: unknown&#x000a0;<sup>5</sup></p>
                      </list-item>
                      <list-item>
                        <p>EEIE16: unknown&#x000a0;<sup>6</sup></p>
                      </list-item>
                      <list-item>
                        <p>DFNB86: unknown&#x000a0;<sup>7</sup></p>
                      </list-item>
                      <list-item>
                        <p>DFNA65: unknown&#x000a0;<sup>8</sup></p>
                      </list-item>
                    </list>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_tbc1d24-dis.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>DOORS = deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures</p>
              </fn>
              <fn>
                <p>FIME = familial infantile myoclonic epilepsy</p>
              </fn>
              <fn>
                <p>PME = progressive myoclonus epilepsy</p>
              </fn>
              <fn>
                <p>EEIE = early-infantile epileptic encephalopathy</p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="tbc1d24-dis" object-id="tbc1d24-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name. See <xref ref-type="sec" rid="tbc1d24-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al [2014]</xref>
                </p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="tbc1d24-dis.REF.corbett.2010.371">Corbett et al [2010]</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.falace.2010.365">Falace et al [2010]</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.afawi.2013.240">Afawi et al [2013]</xref></p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="tbc1d24-dis.REF.muona.2015.39">Muona et al [2015]</xref>
                </p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun [2013]</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.milh.2013.869">Milh et al [2013]</xref></p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="tbc1d24-dis.REF.rehman.2014.144">Rehman et al [2014]</xref>
                </p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="tbc1d24-dis.REF.azaiez.2014.819">Azaiez et al [2014]</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.zhang.2014.814">Zhang et al [2014]</xref></p>
              </fn>
              <fn id="tbc1d24-dis.TF.1.9">
                <label>9. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="tbc1d24-dis.Clinical_Description">
          <title>Clinical Description</title>
          <sec id="tbc1d24-dis.DOORS_Syndrome">
            <title>DOORS Syndrome</title>
            <p><bold>The five major features of DOORS syndrome</bold> are profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability/global developmental delay, and seizures [<xref ref-type="bibr" rid="tbc1d24-dis.REF.james.2007.2821">James et al 2007</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
            <p>The sensorineural hearing loss is often profound and prelingual. Some have benefited from cochlear implants.</p>
            <p>The onycho-osteodystrophy affects the hands and feet equally. Small or absent nails (onychodystrophy) and hypoplastic terminal phalanges (osteodystrophy) are noted in most individuals. A triphalangeal thumb is present in one third of affected individuals.</p>
            <p>The degree of intellectual disability (previously referred to as mental retardation) can vary significantly but is often severe. The motor and language skills were most delayed in two children where such details are available [<xref ref-type="bibr" rid="tbc1d24-dis.REF.nomura.2009.75">Nomura et al 2009</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.girish.2011.479">Girish et al 2011</xref>]. One child had autism spectrum disorder [<xref ref-type="bibr" rid="tbc1d24-dis.REF.nomura.2009.75">Nomura et al 2009</xref>].</p>
            <p>Seizures, present in most individuals with DOORS syndrome, usually start in the first year of life. The seizures are more often generalized tonic-clonic, but myoclonic, partial, and absence seizures also occur. Occasionally their frequency or severity increases. In several instances, the seizures have been difficult to control even with multiple antiepileptic medications and have led to status epilepticus and death.</p>
            <p>On MRI hyperintense T<sub>2</sub> signal anomalies may be observed in the cerebellar hemispheres and the frontal region [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
            <p><bold>Other.</bold> A wide nasal base and a bulbous nose are the most common facial dysmorphisms. Other findings in a minority of individuals include narrow or high arched palate, broad alveolar ridge, capillary hemangioma, and short frenulum.</p>
            <p>Cranial anomalies include microcephaly in one third of individuals. Others have a narrow forehead, brachycephaly, or craniosynostosis.</p>
            <p>In individuals with DOORS syndrome and a <italic toggle="yes">TBC1D24</italic> pathogenic variant, the additional anomalies noted are congenital heart defects (double outlet right ventricle), dental anomalies (delayed eruption; wide spacing; and abnormal shape, size, and number), skeletal anomalies (e.g., calcaneal deformities), hypothyroidism, and renal and urinary tract anomalies (e.g., hydronephrosis and nephrocalcinosis) [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
            <p>A large proportion of individuals with DOORS syndrome (with and without a <italic toggle="yes">TBC1D24</italic> pathogenic variant) have elevated levels of urinary 2-oxoglutaric acid, which can fluctuate between normal and elevated over time [<xref ref-type="bibr" rid="tbc1d24-dis.REF.patton.1987.207">Patton et al 1987</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.van_bever.2007.763">van Bever et al 2007</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
            <p>In some individuals with DOORS syndrome whose genetic status is unknown (i.e., who did not undergo <italic toggle="yes">TBC1D24</italic> testing or did not have an identified <italic toggle="yes">TBC1D24</italic> pathogenic variant) the following anomalies can be noted.</p>
            <list list-type="bullet">
              <list-item>
                <p>In most, vision is normal but optic neuropathy or visual impairment has been noted in a minority.</p>
              </list-item>
              <list-item>
                <p>Peripheral neuropathy was seen in three individuals.</p>
              </list-item>
              <list-item>
                <p>Congenital heart defects (atrial or ventricular septal defects), and renal and urinary tract anomalies (e.g., duplicated kidney, cystic dysplastic kidneys, hydronephrosis) were seen in several individuals [<xref ref-type="bibr" rid="tbc1d24-dis.REF.james.2007.2821">James et al 2007</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="tbc1d24-dis.Familial_Infantile_Myoclonic">
            <title>Familial Infantile Myoclonic Epilepsy (FIME)</title>
            <p>FIME is characterized by early-onset myoclonic seizures.</p>
            <p>Findings include focal epilepsy, dysarthria, mild-to-moderate intellectual disability, and cortical thickening and cerebellar atrophy with high T<sub>2</sub> and FLAIR on MRI (in 4 sibs of an Israeli Arab family [<xref ref-type="bibr" rid="tbc1d24-dis.REF.corbett.2010.371">Corbett et al 2010</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.afawi.2013.240">Afawi et al 2013</xref>]).</p>
            <p>Intellect may be normal: all seven members of an Italian family who had FIME and biallelic <italic toggle="yes">TBC1D24</italic> pathogenic variants also had normal intelligence. Six had normal brain MRI and one had periventricular nodular heterotopia [<xref ref-type="bibr" rid="tbc1d24-dis.REF.zara.2000.1552">Zara et al 2000</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.de_falco.2001.1541">de Falco et al 2001</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.falace.2010.365">Falace et al 2010</xref>].</p>
          </sec>
          <sec id="tbc1d24-dis.Progressive_Myoclonus_Epilep">
            <title>Progressive Myoclonus Epilepsy (PME)</title>
            <p>PME is characterized by action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia.</p>
            <p>For the child described with PME caused by mutation of <italic toggle="yes">TBC1D24</italic>, tonic seizures started at age 36 hours. Developmental delay with later regression was then noted. Myoclonus started at age eight months and tonic-clonic seizures at age 3.5 years. Ataxia, spasticity, supranuclear gaze palsy, and visual decline were also noted. Although the initial clinical diagnosis was of an epileptic encephalopathy, a florid PME pattern was apparent by age nine years [<xref ref-type="bibr" rid="tbc1d24-dis.REF.muona.2015.39">Muona et al 2015</xref>]. There were no digital anomalies or deafness [Sam Berkovic, MD, personal communication].</p>
          </sec>
          <sec id="tbc1d24-dis.EarlyInfantile_Epileptic_Enc">
            <title>Early-Infantile Epileptic Encephalopathy 16 (EIEE16)</title>
            <p>Epileptic encephalopathies are defined by the International League Against Epilepsy (ILAE) as conditions in which epileptiform EEG abnormalities themselves are believed to contribute to progressive disturbance in cerebral function [<xref ref-type="bibr" rid="tbc1d24-dis.REF.engel.2001.796">Engel 2001</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.berg.2010.676">Berg et al 2010</xref>].</p>
            <p>Findings may include:</p>
            <list list-type="bullet">
              <list-item>
                <p>Myoclonic epilepsy with episodic dystonia, hemiparesis, autonomic signs, and lethargy evolving to chronic dystonia, progressive diffuse cerebral atrophy, and early death (in 5 Turkish families [<xref ref-type="bibr" rid="tbc1d24-dis.REF.duru.2010.207">Duru et al 2010</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun 2013</xref>]);</p>
              </list-item>
              <list-item>
                <p>Malignant migrating partial seizures in infancy with progressive diffuse cerebral atrophy of the gray matter (sparing the posterior fossa) and early death (in 2 French sibs [<xref ref-type="bibr" rid="tbc1d24-dis.REF.milh.2013.869">Milh et al 2013</xref>]).</p>
              </list-item>
            </list>
          </sec>
          <sec id="tbc1d24-dis.Autosomal_Recessive_Nonsyndr">
            <title>Autosomal Recessive Nonsyndromic Hearing Loss, DFNB86</title>
            <p>Findings observed include profound prelingual deafness with hearing thresholds above 90 dB for all test frequencies (in 2 consanguineous Pakistani families<italic toggle="yes">;</italic> 1 affected family member and 1 carrier also had seizures [<xref ref-type="bibr" rid="tbc1d24-dis.REF.rehman.2014.144">Rehman et al 2014</xref>]) (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
          </sec>
          <sec id="tbc1d24-dis.Autosomal_Dominant_Nonsyndro">
            <title>Autosomal Dominant Nonsyndromic Hearing Loss, DFNA65</title>
            <p>Findings include slowly progressive deafness with onset in the third decade, initially affecting the high frequencies (in 1 Chinese family [<xref ref-type="bibr" rid="tbc1d24-dis.REF.zhang.2014.814">Zhang et al 2014</xref>] and in a family of European descent [<xref ref-type="bibr" rid="tbc1d24-dis.REF.azaiez.2014.819">Azaiez et al 2014</xref>]) (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
          </sec>
        </sec>
        <sec id="tbc1d24-dis.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>The <italic toggle="yes">TBC1D24</italic> pathogenic variants that cause DOORS syndrome, FIME, EIEE16, DFNB86, and DFNA65 are located at different residues without a pattern emerging to date. Pathogenic variants causing one phenotype have not been demonstrated to cause the others either within the same family or in different families. Thus, while there appears to be a clear genotype-phenotype correlation, the location and type of new pathogenic variants cannot yet be used to predict a phenotype. This may change as more pathogenic variants are identified.</p>
        </sec>
        <sec id="tbc1d24-dis.Nomenclature">
          <title>Nomenclature</title>
          <p>The acronym &#x0201c;DOOR syndrome&#x0201d; was coined in 1975 [<xref ref-type="bibr" rid="tbc1d24-dis.REF.cantwell.1975.261">Cantwell 1975</xref>]. Subsequently, <xref ref-type="bibr" rid="tbc1d24-dis.REF.qazi.1984.391">Qazi &#x00026; Nangia [1984]</xref> suggested adding an S (DOORS syndrome) because of the seizures present in most individuals. Other terms used for this condition include digito-reno-cerebral syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.eronen.1985.281">Eronen et al 1985</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.winter.1993.167">Winter 1993</xref>] and Eronen syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.le_merrer.1992.196">Le Merrer et al 1992</xref>].</p>
          <p>EIEE16 has also been referred to as malignant migrating partial seizures of infancy (MMPSI) [<xref ref-type="bibr" rid="tbc1d24-dis.REF.milh.2013.869">Milh et al 2013</xref>], which is also known as epilepsy of infancy with migrating focal seizures.</p>
        </sec>
        <sec id="tbc1d24-dis.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">TBC1D24</italic>-related disorders is very low. Fewer than 50 families with DOORS syndrome are known, and fewer than five each for the other <italic toggle="yes">TBC1D24</italic>-related disorders.</p>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>All the phenotypes known to be associated with mutation of <italic toggle="yes">TBC1D24</italic> are included in this <italic toggle="yes">GeneReview</italic>.</p>
      </sec>
      <sec id="tbc1d24-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <sec id="tbc1d24-dis.DOORS_Syndrome_1">
          <title>DOORS Syndrome</title>
          <p><bold>Non-<italic toggle="yes">TBC1D24</italic> related DOORS syndrome.</bold> Since nine of 18 families with DOORS syndrome did not have pathogenic variants identified in <italic toggle="yes">TBC1D24</italic>, genetic heterogeneity for this condition is likely. Exome analysis in some of these families did not reveal a commonly mutated gene [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>], but an extension of this study is ongoing.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="coffin-siris" document-type="chapter"><bold>Coffin-Siris syndrome</bold></related-object>
<bold>(CSS)</bold> is characterized by aplasia or hypoplasia of the distal phalanx or nail of the fifth digit, distinctive facial features, and moderate-to-severe developmental/cognitive delay. Expressive language is more severely affected than receptive language. On average, children with CSS learn to sit at 12 months, walk at 30 months, and speak their first words at 24 months. Other findings commonly include failure to thrive, feeding difficulties, short stature, ophthalmologic abnormalities, microcephaly, brain malformations, and hearing loss. CSS caused by a heterozygous pathogenic variant in one of five genes (<italic toggle="yes">ARID1A</italic>, <italic toggle="yes">ARID1B</italic>, <italic toggle="yes">SMARCA4</italic>, <italic toggle="yes">SMARCB1</italic>, and <italic toggle="yes">SMARCE1</italic>) is inherited in an autosomal dominant manner, but most commonly results from a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
          <p>While some individuals with a phenotype resembling <italic toggle="yes">TBC1D24</italic>-associated DOORS syndrome have been found to have a <italic toggle="yes">de novo SMARCB1</italic> pathogenic variant, their distinguishing features include retinal anomalies, Dandy-Walker malformation, scoliosis, and respiratory difficulties. Moreover, they did not have seizures or 2-oxoglutaric aciduria [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.327">Campeau &#x00026; Hennekam 2014</xref>].</p>
          <p><bold>Dominant deafness-onychodystrophy (DDOD) syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/124480">OMIM</ext-link>) is characterized by congenital sensorineural deafness, onychodystrophy, and conical, hypoplastic teeth. In contrast with DOORS syndrome, DDOD syndrome is not associated with intellectual disability or seizures [<xref ref-type="bibr" rid="tbc1d24-dis.REF.yuan.2014.1370">Yuan et al 2014</xref>]. Inheritance is autosomal dominant. <xref ref-type="bibr" rid="tbc1d24-dis.REF.yuan.2014.1370">Yuan et al [2014]</xref> identified the same <italic toggle="yes">de novo</italic>
<italic toggle="yes">ATP6V1B2</italic> pathogenic variant in three unrelated individuals with DDOD syndrome.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="nbs" document-type="chapter"><bold>Nicolaides-Baraitser syndrome</bold></related-object><bold>.</bold> Findings include severe intellectual disability, early-onset seizures, short stature, sparse hair, dysmorphic facial features, and thick finger joints. Inheritance is autosomal dominant. <italic toggle="yes">De novo</italic>
<italic toggle="yes">SMARCA2</italic> pathogenic variants have been identified in individuals with Nicolaides-Baraitser syndrome.</p>
          <p><bold>Temple-Baraitser syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611816">OMIM</ext-link>) is a rare developmental disorder; findings include severe intellectual disability, anomalies of the first ray of the upper and lower limbs, and absence/hypoplasia of the nails. A range of dysmorphic facial features have been reported. Inheritance is autosomal dominant. <italic toggle="yes">De novo</italic>
<italic toggle="yes">KCNH1</italic> pathogenic variants have been identified in individuals with Temple-Baraitser syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.simons.2015.73">Simons et al 2015</xref>].</p>
          <p><bold>Zimmermann-Laband syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/135500">OMIM</ext-link>) is a rare disorder; findings include gingival fibromatosis, dysplastic/absent nails, hypoplasia of the distal phalanges, scoliosis, hepatosplenomegaly, hirsutism, abnormalities of the cartilage of the nose and/or ears, and developmental disabilities. Inheritance is autosomal dominant. The gene in which mutation is causative is unknown.</p>
          <p><bold>Mabry syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/239300">OMIM</ext-link>) is also referred to as hyperphosphatasia with mental retardation (intellectual disability). Features in common with DOORS syndrome include the intellectual disability, seizures, short terminal phalanges, and nail hypoplasia. Mabry syndrome is caused by mutation of <italic toggle="yes">PIGV</italic>. 2-oxoglutaric aciduria and deafness do not occur in Mabry syndrome and hyperphosphatasia does not occur in DOORS syndrome.</p>
          <p>In <bold>fetal anticonvulsant syndrome</bold>, children have facial dysmorphisms including epicanthal folds, mid-face hypoplasia, a flat nasal bridge, a small upturned nose, a thin upper lip, a shallow philtrum, and a wide mouth with downturned angles of the mouth [<xref ref-type="bibr" rid="tbc1d24-dis.REF.moore.2000.489">Moore et al 2000</xref>]. They have a narrow or high palate, and dental abnormalities with delayed eruption. Also seen are nail hypoplasia (digit hypoplasia is rarer), joint laxity, talipes equinovarus, developmental delay, intellectual disability, and behavioral disorders including hyperactivity. While otitis media with effusion (glue ear) is often present, deafness or seizures are rare; their absence differentiates children with this disorder from those with DOORS syndrome.</p>
          <p><bold>Conditions with 2-oxoglutaric aciduria.</bold> 2-oxoglutaric aciduria is found in <italic toggle="yes">TBC1D24</italic>-related DOORS syndrome and non-<italic toggle="yes">TBC1D24</italic>-related DOORS syndrome as well as several metabolic disorders without dysmorphisms [<xref ref-type="bibr" rid="tbc1d24-dis.REF.kelley.2002.318">Kelley et al 2002</xref>].</p>
          <p>Other conditions in which 2-oxoglutaric aciduria is observed include disorders of mitochondrial energy metabolism (especially disorders of pyruvate metabolism and the TCA cycle, and defects of the respiratory chain), gluconeogenesis defects, and <related-object link-type="booklink" source-id="gene" document-id="amish-mcph" document-type="chapter">Amish type microcephaly</related-object>.</p>
          <p>In DOORS syndrome, <xref ref-type="bibr" rid="tbc1d24-dis.REF.patton.1987.207">Patton et al [1987]</xref> noted that &#x003b1;-hydroxyglutarate, a metabolite of 2-oxoglutarate, can also be elevated, suggesting that the activity of the 2-oxoglutarate dehydrogenase complex was not abrogated [<xref ref-type="bibr" rid="tbc1d24-dis.REF.patton.1987.207">Patton et al 1987</xref>]. <xref ref-type="bibr" rid="tbc1d24-dis.REF.surendran.2002.371">Surendran et al [2002]</xref> found decreased E1 activity in cells from affected individuals; however, it was normal in cells from a more recently described patient [<xref ref-type="bibr" rid="tbc1d24-dis.REF.james.2007.2821">James et al 2007</xref>].</p>
        </sec>
        <sec id="tbc1d24-dis.Familial_Infantile_Myoclonic_1">
          <title>Familial Infantile Myoclonic Epilepsy (FIME) and Progressive Myoclonus Epilepsy (PME)</title>
          <p>Myoclonic seizures can be seen in juvenile myoclonic epilepsy (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/254770">OMIM</ext-link>) [<xref ref-type="bibr" rid="tbc1d24-dis.REF.harden.2014.150">Harden 2014</xref>], early-infantile myoclonic encephalopathy (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609304">OMIM</ext-link>), and inborn errors of mitochondrial energy metabolism [<xref ref-type="bibr" rid="tbc1d24-dis.REF.cohen.2014.801">Cohen et al 2014</xref>].</p>
          <p>The differential diagnosis of myoclonic epilepsy also includes <related-object link-type="booklink" source-id="gene" document-id="epm1" document-type="chapter">Unverricht-Lundborg disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="lafora" document-type="chapter">Lafora type progressive myoclonus epilepsy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid-lipofuscinoses</related-object>, <related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>, <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-related disorders</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="gefs" document-type="chapter"><italic toggle="yes">SCN1A</italic>-related seizure disorders</related-object>. With the exception of <italic toggle="yes">SCN1A</italic>-related seizure disorders, the myoclonus in these conditions is generally of much later onset than that in <italic toggle="yes">TBC1D24</italic>- related FIME and <italic toggle="yes">TBC1D24</italic>- related PME.</p>
        </sec>
        <sec id="tbc1d24-dis.EarlyInfantile_Epileptic_Enc_1">
          <title>Early-Infantile Epileptic Encephalopathy (EIEE)</title>
          <p>EIEE is a rare form of epilepsy in which affected children develop intractable seizures in the first weeks or months of life resulting in severe developmental disabilities or death in infancy.</p>
          <p>EIEE is genetically heterogeneous. Causes can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Rare copy number variations [<xref ref-type="bibr" rid="tbc1d24-dis.REF.mefford.2011.974">Mefford et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Mutation of an individual gene which may be rare, with fewer than five affected families identified (e.g., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606494"><italic toggle="yes">ST3GAL3</italic></ext-link> (EIEE15), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/139311"><italic toggle="yes">GNAO1</italic></ext-link> (EIEE17) or <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615463"><italic toggle="yes">SZT2</italic></ext-link> (EIEE18)</p>
            </list-item>
            <list-item>
              <p>Mutation of an individual gene which may affect hundreds of individuals (e.g., <italic toggle="yes">SCN1A</italic> (<related-object link-type="booklink" source-id="gene" document-id="gefs" document-type="chapter">Dravet syndrome</related-object>) [<xref ref-type="bibr" rid="tbc1d24-dis.REF.brunklaus.2012.2329">Brunklaus et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Metabolic causes of epileptic encephalopathies such as <related-object link-type="booklink" source-id="gene" document-id="nkh" document-type="chapter">non-ketotic hyperglycinemia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="biotin" document-type="chapter">biotinidase deficiency</related-object>, organic acidemias, cerebral folate deficiency, and <related-object link-type="booklink" source-id="gene" document-id="pds" document-type="chapter">pyridoxine-dependent epilepsy</related-object> [<xref ref-type="bibr" rid="tbc1d24-dis.REF.yu.2013">Yu &#x00026; Pearl 2013</xref>]</p>
            </list-item>
          </list>
          <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS308350">Epileptic encephalopathy, early-infantile &#x02013; OMIM Phenotypic Series</ext-link>, to view genes associated with this phenotype in OMIM.</p>
        </sec>
        <sec id="tbc1d24-dis.Hereditary_Hearing_Loss_and">
          <title>Hereditary Hearing Loss and Deafness</title>
          <p>For the differential diagnosis of hereditary hearing loss and deafness, see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Deafness and Hearing Loss Overview</related-object>.</p>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Management">
        <title>Management</title>
        <sec id="tbc1d24-dis.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">TBC1D24</italic>-related disorder, the following evaluations are recommended:</p>
          <p>
            <bold>DOORS syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical genetics consultation, including dysmorphology examination</p>
            </list-item>
            <list-item>
              <p>Neurology consultation</p>
            </list-item>
            <list-item>
              <p>Audiology consultation</p>
            </list-item>
            <list-item>
              <p>Otolaryngology consultation</p>
            </list-item>
            <list-item>
              <p>Ophthalmology consultation</p>
            </list-item>
            <list-item>
              <p>Dental consultation</p>
            </list-item>
            <list-item>
              <p>Heart ultrasound</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination</p>
            </list-item>
          </list>
          <p><bold>FIME, PME, EIEE16,</bold> and <bold><italic toggle="yes">TBC1D24</italic>-related nonsyndromic deafness syndromes (DFNA65</bold> and <bold>DFNB86).</bold> One should consider some of the above evaluations depending on the clinical signs since the clinical overlap of all <italic toggle="yes">TBC1D24</italic>-related conditions has not yet been fully studied.</p>
        </sec>
        <sec id="tbc1d24-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Deafness.</bold> Consider hearing aids or cochlear implants as needed for hearing loss (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Hearing Loss and Deafness Overview</related-object>). Cochlear implants at age one have been beneficial in one individual with DOORS syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</xref>].</p>
          <p><bold>Developmental delay.</bold> Early educational intervention, physical, occupational and speech therapy is recommended because of the high risk for motor and cognitive delay.</p>
          <p><bold>Seizures.</bold> Symptomatic pharmacologic management is warranted, as no controlled studies have compared the efficacy of different antiepileptic drugs in <italic toggle="yes">TBC1D24</italic>-related disorders.</p>
          <p>The management of epilepsy in many genetic epilepsies is complex; general recommendations from the UK National Institute for Health and Care Excellence are available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nice.org.uk/guidance/cg137">online</ext-link>.</p>
          <p><bold>Renal anomalies.</bold> Refer to an urologist or nephrologist as indicated.</p>
          <p><bold>Heart defects.</bold> Manage according to the anomalies detected.</p>
        </sec>
        <sec id="tbc1d24-dis.Surveillance">
          <title>Surveillance</title>
          <p>Neurology evaluation with EEGs are appropriate, depending on seizure frequency and/or progression of clinical manifestations.</p>
          <p>Perform yearly audiologic evaluation to assess for possible progression of hearing loss and/or the efficacy of hearing aids.</p>
          <p>Yearly dental evaluation is appropriate.</p>
          <p>Individuals with epilepsy, irrespective of cause, should have periodic ECGs as interictal and ictal abnormalities may predispose to sudden unexplained death in epilepsy (SUDEP).</p>
        </sec>
        <sec id="tbc1d24-dis.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Heterozygotes for a <italic toggle="yes">TBC1D24</italic> pathogenic variant causing autosomal dominant deafness, DFNA65, should avoid excessive ambient noise as it may exacerbate hearing loss.</p>
        </sec>
        <sec id="tbc1d24-dis.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>Molecular genetic testing for the familial <italic toggle="yes">TBC1D24</italic> pathogenic variant(s) in older and younger sibs of a proband is appropriate in order to identify as early as possible those who would benefit from early treatment of seizures and/or deafness.</p>
          <p>See <xref ref-type="sec" rid="tbc1d24-dis.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="tbc1d24-dis.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Polyhydramnios is often noted in DOORS syndrome [<xref ref-type="bibr" rid="tbc1d24-dis.REF.james.2007.2821">James et al 2007</xref>].</p>
        </sec>
        <sec id="tbc1d24-dis.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="tbc1d24-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Most <italic toggle="yes">TBC1D24</italic>-related disorders (DOORS syndrome, FIME, PME, EIEE16, and DFNB86) are inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="tbc1d24-dis.Risk_to_Family_Members__Auto">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">TBC1D24</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband.</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with <italic toggle="yes">TBC1D24</italic>-related DOORS syndrome, <italic toggle="yes">TBC1D24</italic>-related PME, and EIEE16 have not reproduced.</p>
            </list-item>
            <list-item>
              <p>The offspring of an individual with a FIME or DFNB86 are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">TBC1D24</italic>.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="tbc1d24-dis.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">TBC1D24</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="tbc1d24-dis.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="tbc1d24-dis.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>Additional points to consider are the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Communication with individuals who are deaf requires the services of a skilled interpreter.</p>
            </list-item>
            <list-item>
              <p>Deaf persons may view deafness as a distinguishing characteristic and not as a handicap, impairment, or medical condition requiring a "treatment" or "cure," or to be "prevented." In fact, having a deaf child may be preferred over having a child with normal hearing.</p>
            </list-item>
            <list-item>
              <p>Many deaf people are interested in obtaining information about the cause of their own deafness including information on medical, educational, and social services rather than information about prevention, reproduction, or family planning. As in all genetic counseling, it is important for the counselor to identify, acknowledge, and respect the individual's/family's questions, concerns, and fears.</p>
            </list-item>
            <list-item>
              <p>The use of certain terms is preferred: probability or chance vs risk; deaf and hard-of-hearing vs hearing impaired. Terms such as "affected," "abnormal," and "disease causing" should be avoided.</p>
            </list-item>
          </list>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="tbc1d24-dis.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TBC1D24</italic> pathogenic variants have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for a <italic toggle="yes">TBC1D24</italic>-related disorder are possible options.</p>
          <p>Requests for prenatal testing for conditions which (like <italic toggle="yes">TBC1D24</italic>-related disorders) have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="tbc1d24-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Transcript variant 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001199107.1">NM_001199107.1</ext-link>) encodes the longest isoform, and is composed of eight exons, with exon 1 being non-coding. Exon 3 is spliced out in isoform 2 (encoded by transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020705.2">NM_020705.2</ext-link>), which is expressed predominantly in non-neural tissues [<xref ref-type="bibr" rid="tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun 2013</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="tbc1d24-dis" object-id="tbc1d24-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="tbc1d24-dis-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> TBC1D24 is a Tre2&#x02013;Bub2&#x02013;Cdc16 (TBC) domain-containing RAB GTPase-activating protein. These catalyze the hydrolysis of GTP by small GTPases (rendering the Rab proteins unable to interact with effectors), thus regulating the proper transport of intracellular vesicles. TBC1D24 is the only TBC/RabGAP protein with a TLDc domain (TBC, LysM, Domain catalytic) of unknown function but thought to be involved in oxidative stress resistance and perhaps to have some enzymatic activity. TBC1D24 has been demonstrated to interact with ARF6 when both proteins are overexpressed in cell culture [<xref ref-type="bibr" rid="tbc1d24-dis.REF.falace.2010.365">Falace et al 2010</xref>, <xref ref-type="bibr" rid="tbc1d24-dis.REF.falace.2014.2337">Falace et al 2014</xref>]. In <italic toggle="yes">C. elegans</italic>, C31H2.1 (a TBC1D24 ortholog) was implicated in synaptic function by an RNAi screen [<xref ref-type="bibr" rid="tbc1d24-dis.REF.sieburth.2005.510">Sieburth et al 2005</xref>]. In <italic toggle="yes">Drosophila</italic>, the ortholog Skywalker (Sky) facilitates endosomal trafficking in synaptic vesicles by facilitating GTP hydrolysis by Rab35, thus controlling synaptic vesicle rejuvenation and neurotransmitter release [<xref ref-type="bibr" rid="tbc1d24-dis.REF.uytterhoeven.2011.117">Uytterhoeven et al 2011</xref>]. Whether human TBC1D24 is able to also facilitate Rab protein-mediated GTP hydrolysis remains to be determined.</p>
        <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">TBC1D24</italic>-related disorders that are inherited in an autosomal recessive manner are thought to be the result of reduced function or loss of function of TBC1D24; however, functional studies of the causative variants are limited.</p>
      </sec>
      <sec id="tbc1d24-dis.References">
        <title>References</title>
        <sec id="tbc1d24-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="tbc1d24-dis.Literature_Cited.reflist0">
            <ref id="tbc1d24-dis.REF.afawi.2013.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelstam</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gecz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation.</article-title>
                <source>Epilepsy Res.</source>
                <year>2013</year>
                <volume>105</volume>
                <fpage>240</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23517570</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.azaiez.2014.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azaiez</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huygen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shearer</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolbe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black-Ziegelbein</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss.</article-title>
                <source>Hum Mutat.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>819</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">24729539</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.berg.2010.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodie</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchhalter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Emde Boas</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glauser</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathern</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosh&#x000e9;</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.</article-title>
                <source>Epilepsia.</source>
                <year>2010</year>
                <volume>51</volume>
                <fpage>676</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">20196795</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.brunklaus.2012.2329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunklaus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reavey</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forbes</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.</article-title>
                <source>Brain.</source>
                <year>2012</year>
                <volume>135</volume>
                <fpage>2329</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">22719002</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.campeau.2014.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>DOORS syndrome collaborative group. DOORS syndrome: phenotype, genotype and comparison with Coffin-Siris syndrome.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <year>2014</year>
                <volume>166C</volume>
                <fpage>327</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">25169651</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.campeau.2014.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasperaviciute</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrage</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000e9;lix</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rump</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aftimos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nair</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begleiter</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bie</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meenakshi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repetto</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blair</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Male</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhaskar</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickerson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giltay</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tostevin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiszniewska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>The genetic basis of DOORS syndrome: an exome-sequencing study.</article-title>
                <source>Lancet Neurol.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>44</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">24291220</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.cantwell.1975.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cantwell</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Congenital sensori-neural deafness associated with onycho-osteo dystrophy and mental retardation (D.O.O.R. syndrome).</article-title>
                <source>Humangenetik.</source>
                <year>1975</year>
                <volume>26</volume>
                <fpage>261</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1132883</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.cohen.2014.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basel-Vanagaite</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg-Stern</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halevy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shuper</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold-Zadok</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behar</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straussberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Two siblings with early infantile myoclonic encephalopathy due to mutation in the gene encoding mitochondrial glutamate/H+ symporter SLC25A22.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2014</year>
                <volume>18</volume>
                <fpage>801</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25033742</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.corbett.2010.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jolly</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coffey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simri</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gecz</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>371</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20797691</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.de_falco.2001.1541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Falco</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santangelo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabile</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bricarelli</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Familial infantile myoclonic epilepsy: clinical features in a large kindred with autosomal recessive inheritance.</article-title>
                <source>Epilepsia.</source>
                <year>2001</year>
                <volume>42</volume>
                <fpage>1541</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11879364</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.duru.2010.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duru</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iseri</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcuk</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolun</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Early-onset progressive myoclonic epilepsy with dystonia mapping to 16pter-p13.3.</article-title>
                <source>J Neurogenet.</source>
                <year>2010</year>
                <volume>24</volume>
                <fpage>207</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">21087195</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.engel.2001.796">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>J</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>International League Against E. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology.</article-title>
                <source>Epilepsia.</source>
                <year>2001</year>
                <volume>42</volume>
                <fpage>796</fpage>
                <lpage>803</lpage>
                <pub-id pub-id-type="pmid">11422340</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.eronen.1985.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eronen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustafsson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraser</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preus</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>New syndrome: A digito-reno-cerebral syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <year>1985</year>
                <volume>22</volume>
                <fpage>281</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">4050858</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.falace.2014.2337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falace</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watrin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippiello</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pallesi-Pocachard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benfenati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Represa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardoso</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>TBC1D24 regulates neuronal migration and maturation through modulation of the ARF6-dependent pathway.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2014</year>
                <volume>111</volume>
                <fpage>2337</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">24469796</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.falace.2010.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falace</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filipello</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Padula</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanni</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Pietri Tonelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Falco</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagna Bricarelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benfenati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>365</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20727515</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.girish.2011.479">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Girish</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mujawar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salodkar</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>DOOR syndrome.</article-title>
                <source>Indian Pediatr.</source>
                <year>2011</year>
                <volume>48</volume>
                <fpage>479</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">21743113</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.guven.2013.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolun</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>TBC1D24 truncating mutation resulting in severe neurodegeneration.</article-title>
                <source>J Med Genet.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>199</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">23343562</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.harden.2014.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harden</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile myoclonic epilepsy-what does the future look like?</article-title>
                <source>Epilepsy Curr.</source>
                <year>2014</year>
                <volume>14</volume>
                <fpage>150</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">24940162</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.james.2007.2821">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Culver</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>DOOR syndrome: clinical report, literature review and discussion of natural history.</article-title>
                <source>Am J Med Gene A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>2821</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">17994565</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.kelley.2002.318">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puffenberger</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <article-title>Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria.</article-title>
                <source>Am J Med Genet.</source>
                <year>2002</year>
                <volume>112</volume>
                <fpage>318</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">12376931</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.le_merrer.1992.196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goutieres</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briard</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Digito-reno-cerebral syndrome: confirmation of Eronen syndrome.</article-title>
                <source>Clin Genet.</source>
                <year>1992</year>
                <volume>42</volume>
                <fpage>196</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1424243</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.mefford.2011.974">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mefford</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yendle</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeg-Olofsson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelakanos</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Rare copy number variants are an important cause of epileptic encephalopathies.</article-title>
                <source>Ann Neurol.</source>
                <year>2011</year>
                <volume>70</volume>
                <fpage>974</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">22190369</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.milh.2013.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falace</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanni</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cacciagli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assereto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benfenati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassio</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy.</article-title>
                <source>Hum Mutat.</source>
                <year>2013</year>
                <volume>34</volume>
                <fpage>869</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">23526554</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.moore.2000.489">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glover</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dean</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>A clinical study of 57 children with fetal anticonvulsant syndromes.</article-title>
                <source>J Med Genet.</source>
                <year>2000</year>
                <volume>37</volume>
                <fpage>489</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">10882750</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.muona.2015.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joensuu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelucci</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markkinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinuper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchetta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Criscuolo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferlazzo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baykan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riguzzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozkara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrade</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelsen</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crespel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindenau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saletti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Privitera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espay</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauffmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duchowny</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;ller</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straussberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samocha</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2015</year>
                <volume>47</volume>
                <fpage>39</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">25401298</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.nomura.2009.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awaya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokochi</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>DOOR syndrome concomitant with non-convulsive status epilepticus and hyperintense cerebellar cortex on T2-weighted imaging.</article-title>
                <source>Brain Dev.</source>
                <year>2009</year>
                <volume>31</volume>
                <fpage>75</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18440741</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.patton.1987.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krywawych</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenton</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baraitser</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): elevated plasma and urinary 2-oxoglutarate in three unrelated patients.</article-title>
                <source>Am J Med Genet.</source>
                <year>1987</year>
                <volume>26</volume>
                <fpage>207</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">3812564</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.qazi.1984.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qazi</surname>
                    <given-names>QH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nangia</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Abnormal distal phalanges and nails, deafness, mental retardation, and seizure disorder: A new familial syndrome.</article-title>
                <source>J Pediatr.</source>
                <year>1984</year>
                <volume>104</volume>
                <fpage>391</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">6707793</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.rehman.2014.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rehman</surname>
                    <given-names>AU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos-Cortez</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morell</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drummond</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basra</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasif</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayub</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raza</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>University of Washington Center for Mendelian Genomics, Nickerson DA, Shendure J, Bamshad M, Riazuddin S, Billington N, Khan SN, Friedman PL, Griffith AJ, Ahmad W, Riazuddin S, Leal SM, Friedman TB. Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2014</year>
                <volume>94</volume>
                <fpage>144</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">24387994</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.sieburth.2005.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sieburth</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ch'ng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dybbs</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavazoie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuy</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rual</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruvkun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Systematic analysis of genes required for synapse structure and function.</article-title>
                <source>Nature.</source>
                <year>2005</year>
                <volume>436</volume>
                <fpage>510</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16049479</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.simons.2015.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rash</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cristofori-Armstrong</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ru</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baillie</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanay</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquinet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debray</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yesil</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleary</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimmond</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGaughran</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabbett</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taft</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2015</year>
                <volume>47</volume>
                <fpage>73</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25420144</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.surendran.2002.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Surendran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michals-Matalon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krywawych</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qazi</surname>
                    <given-names>QH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rady</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyring</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matalon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex.</article-title>
                <source>Am J Med Genet.</source>
                <year>2002</year>
                <volume>113</volume>
                <fpage>371</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12457410</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.uytterhoeven.2011.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uytterhoeven</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuenen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasprowicz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miskiewicz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verstreken</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Loss of skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins.</article-title>
                <source>Cell.</source>
                <year>2011</year>
                <volume>145</volume>
                <fpage>117</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21458671</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.van_bever.2007.763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bever</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duval</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jespers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyskens</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Courtens</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Exclusion of OGDH and BMP4 as candidate genes in two siblings with autosomal recessive DOOR syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>763</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17343268</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.winter.1993.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Eronen syndrome identical with DOOR syndrome?</article-title>
                <source>Clin Genet.</source>
                <month>Mar</month>
                <year>1993</year>
                <volume>43</volume>
                <fpage>167</fpage>
                <pub-id pub-id-type="pmid">8500264</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.yu.2013">
              <mixed-citation publication-type="other">Yu JY, Pearl PL. Metabolic causes of epileptic encephalopathy. Epilepsy Res Treat. 2013;2013:124934.</mixed-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.yuan.2014.1370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome.</article-title>
                <source>Cell Res.</source>
                <year>2014</year>
                <volume>24</volume>
                <fpage>1370</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24913193</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.zara.2000.1552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabile</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbone</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malacarne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santangelo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Falco</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bricarelli</surname>
                    <given-names>FD</given-names>
                  </name>
                </person-group>
                <article-title>Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2000</year>
                <volume>66</volume>
                <fpage>1552</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10741954</pub-id>
              </element-citation>
            </ref>
            <ref id="tbc1d24-dis.REF.zhang.2014.814">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>A dominant mutation in the stereocilia-expressing gene TBC1D24 is a probable cause for nonsyndromic hearing impairment.</article-title>
                <source>Hum Mutat.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>814</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24729547</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="tbc1d24-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="tbc1d24-dis.Author_Notes">
          <title>Author Notes</title>
          <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://recherche.chusj.org/en/Chercheurs/Bio?id=cf14e904-cdaa-4edd-b9a1-daf6fbb71a2c">Philippe M Campeau</ext-link> is Clinical Assistant Professor in Pediatrics at the Sainte-Justine Hospital of the University of Montreal. He is a clinical geneticist with interest in skeletal dysplasias and inborn errors of metabolism, and a principal investigator whose laboratory focuses on understanding the pathophysiology of newly identified skeletal dysplasia genes.</p>
        </sec>
        <sec id="tbc1d24-dis.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors would like to thank the families who participated in our study on DOORS syndrome and made this work possible.</p>
        </sec>
        <sec id="tbc1d24-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>26 February 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>31 July 2014 (pc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
